Reaction
Allergic Granulomatous Angiitis reporting signals
As of the last recalculation, Allergic Granulomatous Angiitis appears in 821 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is MONTELUKAST SODIUM (PRR 372.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Montelukast Sodium | 564 | 372.9 | 374.6 |
| Salmeterol Xinafoate | 21 | 63.4 | 63.5 |
| Theophylline | 22 | 49.8 | 49.9 |
| Theophylline Anhydrous | 22 | 46.2 | 46.3 |
| Omalizumab | 108 | 36.8 | 36.9 |
| Fluticasone Propionate Nasal | 34 | 29.6 | 29.7 |
| Montelukast | 73 | 24.1 | 24.1 |
| Fluticasone Propionate And Salmeterol Xinafoate | 51 | 22.9 | 22.9 |
| Budesonide | 44 | 19.9 | 20.0 |